{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:32Z","timestamp":1759336412936},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Transpl Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40472-016-0114-9","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T06:57:45Z","timestamp":1477378665000},"page":"265-274","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: the Promise and the Stumbling Blocks"],"prefix":"10.1007","volume":"3","author":[{"given":"Mohamed B.","family":"Ezzelarab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"issue":"3","key":"114_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","volume":"10","author":"F Vincenti","year":"2010","unstructured":"Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2010;10(3):535\u201346.","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"issue":"12","key":"114_CR2","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2014121234","volume":"26","author":"DE Hricik","year":"2015","unstructured":"Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, et al. Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients. Journal of the American Society of Nephrology: JASN. 2015;26(12):3114\u201322.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"25","key":"114_CR3","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","volume":"357","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med. 2007;357(25):2562\u201375.","journal-title":"N Engl J Med"},{"issue":"4","key":"114_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","volume":"358","author":"T Kawai","year":"2008","unstructured":"Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353\u201361.","journal-title":"N Engl J Med"},{"issue":"124","key":"114_CR5","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","volume":"4","author":"J Leventhal","year":"2012","unstructured":"Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012;4(124):124ra28.","journal-title":"Sci Transl Med"},{"issue":"8","key":"114_CR6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nri2137","volume":"7","author":"JA Bluestone","year":"2007","unstructured":"Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol. 2007;7(8):650\u20134.","journal-title":"Nat Rev Immunol."},{"issue":"6","key":"114_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","volume":"12","author":"KJ Wood","year":"2012","unstructured":"Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol. 2012;12(6):417\u201330.","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"114_CR8","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","volume":"187","author":"JA Hutchinson","year":"2011","unstructured":"Hutchinson JA, Riquelme P, Sawitzki B, Tomiuk S, Miqueu P, Zuhayra M, et al. Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol. 2011;187(5):2072\u20138.","journal-title":"J Immunol"},{"issue":"6","key":"114_CR9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2015.50","volume":"87","author":"JA Hutchinson","year":"2015","unstructured":"Hutchinson JA, Geissler EK. Now or never? The case for cell-based immunosuppression in kidney transplantation. Kidney Int. 2015;87(6):1116\u201324.","journal-title":"Kidney Int"},{"key":"114_CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fimmu.2016.00015","volume":"7","author":"AW Thomson","year":"2016","unstructured":"Thomson AW, Zahorchak AF, Ezzelarab MB, Butterfield LH, Lakkis FG, Metes DM. Prospective clinical testing of regulatory dendritic cells in organ transplantation. Front Immunol. 2016;7:15.","journal-title":"Front Immunol"},{"issue":"4","key":"114_CR11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","volume":"185","author":"MG Lechner","year":"2010","unstructured":"Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol. 2010;185(4):2273\u201384.","journal-title":"J Immunol"},{"issue":"280","key":"114_CR12","doi-asserted-by":"crossref","first-page":"280rv2","DOI":"10.1126\/scitranslmed.aaa6853","volume":"7","author":"C McDonald-Hyman","year":"2015","unstructured":"\u2022McDonald-Hyman C, Turka LA, Blazar BR. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med. 2015;7(280):280rv2 .The authors provide a schematic review of the mechanisms underlying clinical stem cell and organ allo-transplantation and possible immunomodulatory therapies","journal-title":"Sci Transl Med"},{"issue":"304","key":"114_CR13","doi-asserted-by":"crossref","first-page":"304ps18","DOI":"10.1126\/scitranslmed.aaa7721","volume":"7","author":"P Trzonkowski","year":"2015","unstructured":"Trzonkowski P, Bacchetta R, Battaglia M, Berglund D, Bohnenkamp HR, Ten Brinke A, et al. Hurdles in therapy with regulatory T cells. Sci Transl Med. 2015;7(304):304ps18.","journal-title":"Sci Transl Med"},{"issue":"10","key":"114_CR14","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1681\/ASN.2007111174","volume":"19","author":"O Bestard","year":"2008","unstructured":"Bestard O, Cruzado JM, Rama I, Torras J, Goma M, Seron D, et al. Presence of FoxP3+ regulatory T cells predicts outcome of subclinical rejection of renal allografts. Journal of the American Society of Nephrology : JASN. 2008;19(10):2020\u20136.","journal-title":"Journal of the American Society of Nephrology : JASN."},{"issue":"10","key":"114_CR15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","volume":"11","author":"O Bestard","year":"2011","unstructured":"Bestard O, Cunetti L, Cruzado JM, Lucia M, Valdez R, Olek S, et al. Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11(10):2162\u201372.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"7","key":"114_CR16","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.179.7.4901","volume":"179","author":"O Bestard","year":"2007","unstructured":"Bestard O, Cruzado JM, Mestre M, Caldes A, Bas J, Carrera M, et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol. 2007;179(7):4901\u20139.","journal-title":"J Immunol"},{"issue":"5","key":"114_CR17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1681\/ASN.2008050450","volume":"20","author":"J Ashton-Chess","year":"2009","unstructured":"Ashton-Chess J, Dugast E, Colvin RB, Giral M, Foucher Y, Moreau A, et al. Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. Journal of the American Society of Nephrology : JASN. 2009;20(5):1113\u201322.","journal-title":"Journal of the American Society of Nephrology : JASN."},{"issue":"4","key":"114_CR18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1600-6143.2006.01704.x","volume":"7","author":"F Veronese","year":"2007","unstructured":"Veronese F, Rotman S, Smith RN, Pelle TD, Farrell ML, Kawai T, et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2007;7(4):914\u201322.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"6","key":"114_CR19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1600-6143.2011.03566.x","volume":"11","author":"G Andreola","year":"2011","unstructured":"Andreola G, Chittenden M, Shaffer J, Cosimi AB, Kawai T, Cotter P, et al. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow\/kidney transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11(6):1236\u201347.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"114_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MOT.0b013e328355aaaf","volume":"17","author":"KG MacDonald","year":"2012","unstructured":"MacDonald KG, Orban PC, Levings MK. T regulatory cell therapy in transplantation: stability, localization and functional specialization. Current opinion in organ transplantation. 2012;17(4):343\u20138.","journal-title":"Current opinion in organ transplantation"},{"issue":"10","key":"114_CR21","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.1202027","volume":"189","author":"BE Burrell","year":"2012","unstructured":"Burrell BE, Nakayama Y, Xu J, Brinkman CC, Bromberg JS, Regulatory T. Cell induction, migration, and function in transplantation. J Immunol. 2012;189(10):4705\u201311.","journal-title":"J Immunol"},{"issue":"9","key":"114_CR22","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/ajt.13395","volume":"15","author":"F Braza","year":"2015","unstructured":"\u2022Braza F, Durand M, Degauque N, Brouard S, Regulatory T. Cells in kidney transplantation: new directions? Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(9):2288\u2013300 The authors review recent findings regarding regulatory T cell characterization, and the role of epigenetic programming in Treg stability and function.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1","key":"114_CR23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12173","volume":"259","author":"DV Sawant","year":"2014","unstructured":"\u2022Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunol Rev. 2014;259(1):173\u201391 A critical review of current understating of key intrinsic and extrinsic mechanisms influencing Treg plasticity and stability.","journal-title":"Immunol Rev"},{"issue":"12","key":"114_CR24","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/ajt.12933","volume":"14","author":"Q Tang","year":"2014","unstructured":"\u2022Tang Q. Pharmacokinetics of therapeutic Tregs. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(12):2679\u201380 This commentary highlights the importance of NHP studies in the evaluation of pharmacokinetics of adoptive Treg therapy.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"13","key":"114_CR25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2015-03-634691","volume":"126","author":"BH Koehn","year":"2015","unstructured":"\u2022Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 2015;126(13):1621\u20138 This study provides evidence of the loss of immunsuppressive function of cell therapy under intense inflammatory conditions.","journal-title":"Blood"},{"issue":"6","key":"114_CR26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009;30(6):899\u2013911.","journal-title":"Immunity"},{"issue":"7","key":"114_CR27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI23963","volume":"115","author":"D Valmori","year":"2005","unstructured":"Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest. 2005;115(7):1953\u201362.","journal-title":"J Clin Invest"},{"issue":"5","key":"114_CR28","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.1201379","volume":"190","author":"ME Himmel","year":"2013","unstructured":"Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. Helios\u00a0+\u00a0and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J Immunol. 2013;190(5):2001\u20138.","journal-title":"J Immunol"},{"issue":"83","key":"114_CR29","doi-asserted-by":"crossref","first-page":"83ra42","DOI":"10.1126\/scitranslmed.3002076","volume":"3","author":"P Sagoo","year":"2011","unstructured":"Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, Lombardi G. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med. 2011;3(83):83ra42.","journal-title":"Sci Transl Med"},{"issue":"6","key":"114_CR30","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm.2155","volume":"16","author":"Z Fan","year":"2010","unstructured":"Fan Z, Spencer JA, Lu Y, Pitsillides CM, Singh G, Kim P, et al. In vivo tracking of \u2018color-coded\u2019 effector, natural and induced regulatory T cells in the allograft response. Nat Med. 2010;16(6):718\u201322.","journal-title":"Nat Med"},{"issue":"4","key":"114_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOT.0b013e328355a992","volume":"17","author":"Q Tang","year":"2012","unstructured":"Tang Q, Lee K. Regulatory T-cell therapy for transplantation: how many cells do we need? Current opinion in organ transplantation. 2012;17(4):349\u201354.","journal-title":"Current opinion in organ transplantation."},{"issue":"3","key":"114_CR32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coi.2009.05.021","volume":"21","author":"YK Lee","year":"2009","unstructured":"Lee YK, Mukasa R, Hatton RD, Weaver CT. Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009;21(3):274\u201380.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"114_CR33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2013.10.016","volume":"39","author":"SL Bailey-Bucktrout","year":"2013","unstructured":"\u2022Bailey-Bucktrout SL, Martinez-Llordella M, Zhou X, Anthony B, Rosenthal W, Luche H, et al. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity. 2013;39(5):949\u201362 This study shows that a subset of self-antigen-specific Treg can loose Foxp3 expression during inflammation and can further contribute to the autoimmune response through production of IFN\u03b3.","journal-title":"Immunity"},{"issue":"9","key":"114_CR34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","volume":"10","author":"X Zhou","year":"2009","unstructured":"Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009;10(9):1000\u20137.","journal-title":"Nat Immunol"},{"issue":"2","key":"114_CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI32562","volume":"118","author":"N Degauque","year":"2008","unstructured":"Degauque N, Mariat C, Kenny J, Zhang D, Gao W, Vu MD, et al. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest. 2008;118(2):735\u201341.","journal-title":"J Clin Invest"},{"issue":"4","key":"114_CR36","doi-asserted-by":"crossref","first-page":"e35572","DOI":"10.1371\/journal.pone.0035572","volume":"7","author":"E Yurchenko","year":"2012","unstructured":"Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, et al. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1\/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS One. 2012;7(4):e35572.","journal-title":"PLoS One"},{"issue":"12","key":"114_CR37","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","volume":"19","author":"A Ueno","year":"2013","unstructured":"\u2022Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19(12):2522\u201334 The authors report on the incidence of double-expressing IL-17 + Foxp3 + CD4 + T cells and plasticity between Th17 and Treg cells in patients with inflammatory bowel disease.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"114_CR38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4161\/hv.20203","volume":"8","author":"E d\u2019Hennezel","year":"2012","unstructured":"d\u2019Hennezel E, Piccirillo CA. Functional plasticity in human FOXP3(+) regulatory T cells: implications for cell-based immunotherapy. Human vaccines & immunotherapeutics. 2012;8(7):1001\u20135.","journal-title":"Human vaccines & immunotherapeutics"},{"issue":"2","key":"114_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trre.2013.02.001","volume":"27","author":"H Yeh","year":"2013","unstructured":"Yeh H, Moore DJ, Markmann JF, Kim JI. Mechanisms of regulatory T cell counter-regulation by innate immunity. Transplant Rev. 2013;27(2):61\u20134.","journal-title":"Transplant Rev"},{"issue":"4","key":"114_CR40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ajt.12647","volume":"14","author":"SC Juvet","year":"2014","unstructured":"Juvet SC, Whatcott AG, Bushell AR, Wood KJ. Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(4):750\u201363.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1","key":"114_CR41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","volume":"20","author":"N Komatsu","year":"2014","unstructured":"\u2022\u2022Komatsu N, Okamoto K, Sawa S, Nakashima T, Oh-hora M, Kodama T, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20(1):62\u20138 The authors report on the acceleration of autoimmune disease in rodents with secondary immunization following adoptive transfer of autoreactive, antigen-experienced CD25 lo Foxp3 + CD4 + T cells, and the prevalence of IL-17 + Foxp3 + T cells in the joints of patients with rheumatoid arthritis.","journal-title":"Nat Med"},{"issue":"7","key":"114_CR42","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2007-01-070748","volume":"110","author":"MD Vu","year":"2007","unstructured":"Vu MD, Xiao X, Gao W, Degauque N, Chen M, Kroemer A, et al. OX40 costimulation turns off Foxp3+ Tregs. Blood. 2007;110(7):2501\u201310.","journal-title":"Blood"},{"issue":"2","key":"114_CR43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","volume":"36","author":"T Miyao","year":"2012","unstructured":"Miyao T, Floess S, Setoguchi R, Luche H, Fehling HJ, Waldmann H, et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity. 2012;36(2):262\u201375.","journal-title":"Immunity"},{"issue":"2","key":"114_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nri2474","volume":"9","author":"J Huehn","year":"2009","unstructured":"Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol. 2009;9(2):83\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"114_CR45","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.03180509","volume":"4","author":"SA De Serres","year":"2009","unstructured":"De Serres SA, Sayegh MH, Najafian N. Immunosuppressive drugs and Tregs: a critical evaluation. Clinical journal of the American Society of Nephrology : CJASN. 2009;4(10):1661\u20139.","journal-title":"Clinical journal of the American Society of Nephrology : CJASN"},{"issue":"12","key":"114_CR46","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/j.1600-6143.2012.04269.x","volume":"12","author":"T Akimova","year":"2012","unstructured":"Akimova T, Kamath BM, Goebel JW, Meyers KE, Rand EB, Hawkins A, et al. Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(12):3449\u201361.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"11","key":"114_CR47","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2009.02820.x","volume":"9","author":"A Sener","year":"2009","unstructured":"Sener A, Tang AL, Farber DL, Memory T. Cell predominance following T-cell depletional therapy derives from homeostatic expansion of naive T cells. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2009;9(11):2615\u201323.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"114_CR48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1600-6143.2010.03050.x","volume":"10","author":"DJ Windt van der","year":"2010","unstructured":"van der Windt DJ, Smetanka C, Macedo C, He J, Lakomy R, Bottino R, et al. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(4):773\u201383.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"2","key":"114_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","volume":"117","author":"C King","year":"2004","unstructured":"King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell. 2004;117(2):265\u201377.","journal-title":"Cell"},{"issue":"1","key":"114_CR50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2004.10.022","volume":"98","author":"A Khoruts","year":"2005","unstructured":"Khoruts A, Fraser JMA. Causal link between lymphopenia and autoimmunity. Immunol Lett. 2005;98(1):23\u201331.","journal-title":"Immunol Lett"},{"issue":"2","key":"114_CR51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","volume":"109","author":"D Golshayan","year":"2007","unstructured":"Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4\u00a0+\u00a0CD25+ regulatory T cells promote experimental transplantation tolerance. Blood. 2007;109(2):827\u201335.","journal-title":"Blood"},{"issue":"2","key":"114_CR52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-6143.2007.02088.x","volume":"8","author":"G Xia","year":"2008","unstructured":"Xia G, He J, Leventhal JR. Ex vivo-expanded natural CD4\u00a0+\u00a0CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2008;8(2):298\u2013306.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1","key":"114_CR53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","volume":"14","author":"O Joffre","year":"2008","unstructured":"Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, et al. Prevention of acute and chronic allograft rejection with CD4\u00a0+\u00a0CD25\u00a0+\u00a0Foxp3+ regulatory T lymphocytes. Nat Med. 2008;14(1):88\u201392.","journal-title":"Nat Med"},{"key":"114_CR54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2172-13-70","volume":"13","author":"CQ Xia","year":"2012","unstructured":"Xia CQ, Chernatynskaya AV, Wasserfall CH, Wan S, Looney BM, Eisenbeis S, et al. Anti-thymocyte globulin (ATG) differentially depletes naive and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice. BMC Immunol. 2012;13:70.","journal-title":"BMC Immunol"},{"issue":"10","key":"114_CR55","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1681\/ASN.2006050422","volume":"17","author":"M Lopez","year":"2006","unstructured":"Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian NA. Novel mechanism of action for anti-thymocyte globulin: induction of CD4\u00a0+\u00a0CD25\u00a0+\u00a0Foxp3+ regulatory T cells. Journal of the American Society of Nephrology : JASN. 2006;17(10):2844\u201353.","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"7","key":"114_CR56","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1182\/blood-2008-01-130146","volume":"111","author":"X Feng","year":"2008","unstructured":"Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4\u00a0+\u00a0CD25highFOXP3+ regulatory T cells in vitro. Blood. 2008;111(7):3675\u201383.","journal-title":"Blood"},{"issue":"4","key":"114_CR57","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1600-6143.2011.03978.x","volume":"12","author":"O Boenisch","year":"2012","unstructured":"Boenisch O, Lopez M, Elyaman W, Magee CN, Ahmad U, Najafian N. Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4(+) T cells and requires the presence of monocytes. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(4):856\u201366.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"114_CR58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.tp.0000165847.05787.08","volume":"80","author":"G Ciancio","year":"2005","unstructured":"Ciancio G, Burke GW, Gaynor JJ, Carreno MR, Cirocco RE, Mathew JM, et al. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation. 2005;80(4):457\u201365.","journal-title":"Transplantation"},{"issue":"4","key":"114_CR59","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","volume":"12","author":"LV Riella","year":"2012","unstructured":"Riella LV, Liu T, Yang J, Chock S, Shimizu T, Mfarrej B, et al. Deleterious effect of CTLA4-Ig on a treg-dependent transplant model. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(4):846\u201355.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"9","key":"114_CR60","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1600-6143.2012.04184.x","volume":"12","author":"LM Charbonnier","year":"2012","unstructured":"Charbonnier LM, Vokaer B, Lemaitre PH, Field KA, Leo O, Le Moine A. CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(9):2313\u201321.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"114_CR61","unstructured":"\u2022Schwarz C, Unger L, Mahr B, Aumayr K, Regele H, Farkas AM et al. The immunosupressive effect of CTLA4Ig is treg-dependent at low, but not at high doses. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016;In press. This study suggests that low-dose of costimulation blockade by CTLA4Ig may not be detrimental to Treg after transplantation."},{"issue":"5","key":"114_CR62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1432-2277.2011.01223.x","volume":"24","author":"O Bestard","year":"2011","unstructured":"Bestard O, Cassis L, Cruzado JM, Torras J, Franquesa M, Gil-Vernet S, et al. Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation. Transpl Int. 2011;24(5):451\u201360.","journal-title":"Transpl Int"},{"issue":"3","key":"114_CR63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.immuni.2008.12.022","volume":"30","author":"N Zhang","year":"2009","unstructured":"Zhang N, Schroppel B, Lal G, Jakubzick C, Mao X, Chen D, et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. 2009;30(3):458\u201369.","journal-title":"Immunity"},{"issue":"11","key":"114_CR64","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.174.11.6993","volume":"174","author":"JC Ochando","year":"2005","unstructured":"Ochando JC, Yopp AC, Yang Y, Garin A, Li Y, Boros P, et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol. 2005;174(11):6993\u20137005.","journal-title":"J Immunol"},{"issue":"1","key":"114_CR65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.176.1.329","volume":"176","author":"A Sanchez-Fueyo","year":"2006","unstructured":"Sanchez-Fueyo A, Sandner S, Habicht A, Mariat C, Kenny J, Degauque N, et al. Specificity of CD4\u00a0+\u00a0CD25+ regulatory T cell function in alloimmunity. J Immunol. 2006;176(1):329\u201334.","journal-title":"J Immunol"},{"issue":"11","key":"114_CR66","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1172\/JCI33185","volume":"118","author":"JY Tsang","year":"2008","unstructured":"Tsang JY, Tanriver Y, Jiang S, Xue SA, Ratnasothy K, Chen D, et al. Conferring indirect allospecificity on CD4\u00a0+\u00a0CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest. 2008;118(11):3619\u201328.","journal-title":"J Clin Invest"},{"issue":"2","key":"114_CR67","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.0900936","volume":"184","author":"G Raimondi","year":"2010","unstructured":"Raimondi G, Sumpter TL, Matta BM, Pillai M, Corbitt N, Vodovotz Y, et al. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J Immunol. 2010;184(2):624\u201336.","journal-title":"J Immunol"},{"issue":"11","key":"114_CR68","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","volume":"112","author":"A Trenado","year":"2003","unstructured":"Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, et al. Recipient-type specific CD4\u00a0+\u00a0CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest. 2003;112(11):1688\u201396.","journal-title":"J Clin Invest"},{"issue":"7","key":"114_CR69","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nm.2154","volume":"16","author":"SN Nadig","year":"2010","unstructured":"Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, et al. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med. 2010;16(7):809\u201313.","journal-title":"Nat Med"},{"issue":"11","key":"114_CR70","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","volume":"13","author":"AL Putnam","year":"2013","unstructured":"Putnam AL, Safinia N, Medvec A, Laszkowska M, Wray M, Mintz MA, et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(11):3010\u201320.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"114_CR71","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","volume":"126","author":"KG MacDonald","year":"2016","unstructured":"\u2022\u2022MacDonald KG, Hoeppli RE, Huang Q, Gillies J, Luciani DS, Orban PC, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126(4):1413\u201324 The authors use chimeric antigen receptor (CAR) technology to generate and enrich for human allo-antigen specific Treg.","journal-title":"J Clin Invest"},{"issue":"16","key":"114_CR72","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371(16):1507\u201317.","journal-title":"N Engl J Med"},{"issue":"303","key":"114_CR73","doi-asserted-by":"crossref","first-page":"303ra139","DOI":"10.1126\/scitranslmed.aac5415","volume":"7","author":"DL Porter","year":"2015","unstructured":"Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, et al. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. 2015;7(303):303ra139.","journal-title":"Sci Transl Med"},{"issue":"8","key":"114_CR74","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/j.1600-6143.2011.03635.x","volume":"11","author":"B Afzali","year":"2011","unstructured":"Afzali B, Mitchell PJ, Scotta C, Canavan J, Edozie FC, Fazekasova H, et al. Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11(8):1734\u201342.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"86","key":"114_CR75","doi-asserted-by":"crossref","first-page":"86ra51","DOI":"10.1126\/scitranslmed.3002093","volume":"3","author":"O Nadazdin","year":"2011","unstructured":"Nadazdin O, Boskovic S, Murakami T, Tocco G, Smith RN, Colvin RB, et al. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med. 2011;3(86):86ra51.","journal-title":"Sci Transl Med"},{"issue":"6","key":"114_CR76","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1600-6143.2010.03119.x","volume":"10","author":"O Nadazdin","year":"2010","unstructured":"Nadazdin O, Boskovic S, Murakami T, O\u2019Connor DH, Wiseman RW, Karl JA, et al. Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(6):1375\u201384.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"3","key":"114_CR77","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","volume":"5","author":"JP Pearl","year":"2005","unstructured":"Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2005;5(3):465\u201374.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"5","key":"114_CR78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1600-6143.2006.01703.x","volume":"7","author":"I Koyama","year":"2007","unstructured":"Koyama I, Nadazdin O, Boskovic S, Ochiai T, Smith RN, Sykes M, et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2007;7(5):1055\u201361.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1\u20134","key":"114_CR79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trim.2013.10.002","volume":"29","author":"MR Marco","year":"2013","unstructured":"Marco MR, Dons EM, van der Windt DJ, Bhama JK, Lu LT, Zahorchak AF, et al. Post-transplant repopulation of naive and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys. Transpl Immunol. 2013;29(1\u20134):88\u201398.","journal-title":"Transpl Immunol"},{"issue":"5 Pt 1","key":"114_CR80","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1600-6143.2006.01260.x","volume":"6","author":"LS Kean","year":"2006","unstructured":"Kean LS, Gangappa S, Pearson TC, Larsen CP. Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2006;6(5 Pt 1):884\u201393.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"5","key":"114_CR81","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.intimp.2010.11.001","volume":"11","author":"A Ma","year":"2011","unstructured":"Ma A, Qi S, Song L, Hu Y, Dun H, Massicotte E, et al. Adoptive transfer of CD4\u00a0+\u00a0CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in cynomolgus monkeys. Int Immunopharmacol. 2011;11(5):618\u201329.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"114_CR82","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1111\/j.1600-6143.2008.02376.x","volume":"8","author":"A Anderson","year":"2008","unstructured":"Anderson A, Martens CL, Hendrix R, Stempora LL, Miller WP, Hamby K, et al. Expanded nonhuman primate Tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2008;8(11):2252\u201364.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"8","key":"114_CR83","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/ajt.12248","volume":"13","author":"EM Dons","year":"2013","unstructured":"Dons EM, Raimondi G, Zhang H, Zahorchak AF, Bhama JK, Lu L, et al. Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2013;13(8):2169\u201378.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"8","key":"114_CR84","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/TP.0b013e3181ebf782","volume":"90","author":"EM Dons","year":"2010","unstructured":"Dons EM, Raimondi G, Cooper DK, Thomson AW. Non-human primate regulatory T cells: current biology and implications for transplantation. Transplantation. 2010;90(8):811\u20136.","journal-title":"Transplantation"},{"issue":"9","key":"114_CR85","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.4049\/jimmunol.172.9.5753","volume":"172","author":"JR Torrealba","year":"2004","unstructured":"Torrealba JR, Katayama M, Fechner Jr JH, Jankowska-Gan E, Kusaka S, Xu Q, et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1\u00a0+\u00a0CD4+ T regulatory cell infiltrates. J Immunol. 2004;172(9):5753\u201364.","journal-title":"J Immunol"},{"issue":"7","key":"114_CR86","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1172\/JCI23743","volume":"115","author":"H Bashuda","year":"2005","unstructured":"Bashuda H, Kimikawa M, Seino K, Kato Y, Ono F, Shimizu A, et al. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Investig. 2005;115(7):1896\u2013902.","journal-title":"J Clin Investig"},{"issue":"6","key":"114_CR87","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1600-6143.2011.03963.x","volume":"12","author":"K Singh","year":"2012","unstructured":"Singh K, Kozyr N, Stempora L, Kirk AD, Larsen CP, Blazar BR, et al. Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2012;12(6):1441\u201357.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"12","key":"114_CR88","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/ajt.12934","volume":"14","author":"K Singh","year":"2014","unstructured":"\u2022Singh K, Stempora L, Harvey RD, Kirk AD, Larsen CP, Blazar BR, et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14(12):2691\u2013703 The authors report on the pharmacokinetics of Treg following their adoptive transfer into rhesus monkeys receiving either rapamycin or tacrolimus.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"5","key":"114_CR89","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ajt.13113","volume":"15","author":"H Zhang","year":"2015","unstructured":"\u2022Zhang H, Guo H, Lu L, Zahorchak AF, Wiseman RW, Raimondi G, et al. Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(5):1253\u201366 The authors report on the pharmacokinetics of autologous or allogeneic Treg following their adoptive transfer into lymphodepleted cynomolgus monkeys.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1","key":"114_CR90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cellimm.2015.02.006","volume":"295","author":"H Guo","year":"2015","unstructured":"Guo H, Zhang H, Lu L, Ezzelarab MB, Thomson AW. Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells. Cell Immunol. 2015;295(1):19\u201328.","journal-title":"Cell Immunol"},{"key":"114_CR91","doi-asserted-by":"crossref","unstructured":"\u2022\u2022Ezzelarab MB, Zhang H, Guo H, Lu L, Zahorchak AF, Wiseman RW, et al. Regulatory T cell infusion can enhance memory T cell and alloantibody responses in lymphodepleted nonhuman primate heart allograft recipients. Am J Transplant 2016;16:1999\u20132015. This study reports adverse effects on allograft survival of polyclonal Treg infusion early after transplantation in lymphodepleted monkeys.","DOI":"10.1111\/ajt.13685"},{"issue":"9","key":"114_CR92","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","volume":"10","author":"S Gurkan","year":"2010","unstructured":"Gurkan S, Luan Y, Dhillon N, Allam SR, Montague T, Bromberg JS, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2010;10(9):2132\u201341.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"1","key":"114_CR93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/tri.12448","volume":"28","author":"R Valdez-Ortiz","year":"2015","unstructured":"\u2022Valdez-Ortiz R, Bestard O, Llaudo I, Franquesa M, Cerezo G, Torras J, et al. Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation. Transpl Int. 2015;28(1):108\u201319 This study suggests that lymphodepletion with ATG may promote suppressive Treg after transplantation.","journal-title":"Transpl Int"},{"issue":"12","key":"114_CR94","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e3181ff8772","volume":"90","author":"F Issa","year":"2010","unstructured":"Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation. 2010;90(12):1321\u20137.","journal-title":"Transplantation"},{"issue":"1","key":"114_CR95","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","volume":"133","author":"P Trzonkowski","year":"2009","unstructured":"Trzonkowski P, Bieniaszewska M, Juscinska J, Dobyszuk A, Krzystyniak A, Marek N, et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4\u00a0+\u00a0CD25\u00a0+\u00a0CD127- T regulatory cells. Clin Immunol. 2009;133(1):22\u20136.","journal-title":"Clin Immunol"},{"issue":"14","key":"114_CR96","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","volume":"117","author":"M Di Ianni","year":"2011","unstructured":"Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14):3921\u20138.","journal-title":"Blood"},{"issue":"3","key":"114_CR97","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","volume":"117","author":"CG Brunstein","year":"2011","unstructured":"Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3):1061\u201370.","journal-title":"Blood"},{"key":"114_CR98","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","volume":"5","author":"R Bacchetta","year":"2014","unstructured":"\u2022Bacchetta R, Lucarelli B, Sartirana C, Gregori S, Lupo Stanghellini MT, Miqueu P, et al. Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front Immunol. 2014;5:16 .In this clinical trial, IL-10-anergized donor T cells containing Tr1 Treg specific for host allo-antigens limited graft-versus-host allo-reactivity and improved engraftment","journal-title":"Front Immunol"},{"key":"114_CR99","doi-asserted-by":"crossref","unstructured":"\u2022\u2022Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, et al. A pilot study of operational tolerance with a regulatory T cell-based cell therapy in living donor liver transplantation. Hepatology. 2016; This study reports on the safety and preliminary efficacy of Treg-enriched host anergic T cells infused after transplantation.","DOI":"10.1002\/hep.28459"}],"container-title":["Current Transplantation Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40472-016-0114-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40472-016-0114-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40472-016-0114-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T00:30:54Z","timestamp":1568507454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40472-016-0114-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1007\/s40472-016-0114-9","relation":{},"ISSN":["2196-3029"],"issn-type":[{"value":"2196-3029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}